Jérémie Vitte

1.2k total citations
21 papers, 772 citations indexed

About

Jérémie Vitte is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Jérémie Vitte has authored 21 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Jérémie Vitte's work include Neurofibromatosis and Schwannoma Cases (12 papers), Meningioma and schwannoma management (5 papers) and Chromatin Remodeling and Cancer (5 papers). Jérémie Vitte is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (12 papers), Meningioma and schwannoma management (5 papers) and Chromatin Remodeling and Cancer (5 papers). Jérémie Vitte collaborates with scholars based in United States, France and Italy. Jérémie Vitte's co-authors include Marco Giovannini, Judith Melki, Natacha Roblot, Coralie Fassier, Laura Papi, Alexander R. Judkins, Giovanni Coppola, Fuying Gao, Theo J.M. Hulsebos and Jean Jacques Hauw and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and Developmental Cell.

In The Last Decade

Jérémie Vitte

19 papers receiving 762 citations

Peers

Jérémie Vitte

NEURO

GENET

CMN

EPIDE

Maria Gardberg Finland

He Lv China

Hyoung Kyun Rha South Korea

Nuria Muelas Spain

Shunji Yunoue Japan

Alexander Schulz Germany

Akihide Kondo Japan

Jonathan Serrano United States

Kiyoshi Onda Japan

Jenny Kan-Suen Pu Hong Kong

Maria Gardberg Finland

Jérémie Vitte

241 ×0.7

332 ×1.0

NEURO

121 ×0.5

GENET

124 ×0.8

CMN

67 ×0.4

EPIDE

Citations per year, relative to Jérémie Vitte Jérémie Vitte (= 1×) peers Maria Gardberg

Countries citing papers authored by Jérémie Vitte

Since Specialization

Citations

This map shows the geographic impact of Jérémie Vitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérémie Vitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérémie Vitte more than expected).

Fields of papers citing papers by Jérémie Vitte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérémie Vitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérémie Vitte. The network helps show where Jérémie Vitte may publish in the future.

Co-authorship network of co-authors of Jérémie Vitte

This figure shows the co-authorship network connecting the top 25 collaborators of Jérémie Vitte. A scholar is included among the top collaborators of Jérémie Vitte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérémie Vitte. Jérémie Vitte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nghiemphu, Phioanh L., Jérémie Vitte, Eva Dombi, et al.. (2024). Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of Neuro-Oncology. 167(2). 339–348. 2 indexed citations

Jonas, Steven J., et al.. (2024). Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells. Biomedicines. 12(9). 1986–1986. 1 indexed citations

Vitte, Jérémie, Ching-Hui Liu, Elizabeth A. Flynn, et al.. (2023). Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Nature Communications. 14(1). 1559–1559. 7 indexed citations

Staedtke, Verena, David M. Bedwell, Marco Giovannini, et al.. (2023). Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials. Clinical Trials. 21(1). 51–66. 7 indexed citations

Sun, Matthew Z., Joey Orpilla, Janet Treger, et al.. (2022). EXTH-87. DECITABINE POTENTIATES MENINGIOMA IMMUNOTHERAPY TARGETING NY-ESO-1. Neuro-Oncology. 24(Supplement_7). vii229–vii229.

Vitte, Jérémie, et al.. (2022). Comparaison des IgE D. pteronyssinus et D. farinae : lequel choisir en pratique clinique ?. Revue française d'allergologie. 62(3). 311–311.

Roberts, Daniel S., Rahul Maurya, Jérémie Vitte, et al.. (2019). Linked-read Sequencing Analysis Reveals Tumor-specific Genome Variation Landscapes in Neurofibromatosis Type 2 (NF2) Patients. Otology & Neurotology. 40(2). e150–e159. 3 indexed citations

Paganini, Irene, Gabriele Lorenzo Capone, Jérémie Vitte, et al.. (2017). Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma. Journal of Neuro-Oncology. 137(1). 33–38. 9 indexed citations

Vitte, Jérémie, Fuying Gao, Giovanni Coppola, Alexander R. Judkins, & Marco Giovannini. (2017). Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development. Nature Communications. 8(1). 300–300. 62 indexed citations

10.

Shi, Yuhao, Saumya Bollam, Shannon M. White, et al.. (2016). Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression. Developmental Cell. 39(4). 452–465. 24 indexed citations

11.

Bonne, N.-X., Jérémie Vitte, Fabrice Chareyre, et al.. (2016). An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth. Journal of Neuro-Oncology. 129(1). 47–56. 11 indexed citations

12.

Paganini, Irene, Vivian Y. Chang, Gabriele Lorenzo Capone, et al.. (2014). Expanding the mutational spectrum of LZTR1 in schwannomatosis. European Journal of Human Genetics. 23(7). 963–968. 57 indexed citations

13.

Giovannini, Marco, N.-X. Bonne, Jérémie Vitte, et al.. (2014). mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. Neuro-Oncology. 16(4). 493–504. 56 indexed citations

14.

Tanaka, Karo, Ascia Eskin, Fabrice Chareyre, et al.. (2013). Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2. Clinical Cancer Research. 19(14). 3856–3870. 28 indexed citations

15.

Plotkin, Scott R., Jaishri O. Blakeley, D. Gareth Evans, et al.. (2013). Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. American Journal of Medical Genetics Part A. 161(3). 405–416. 117 indexed citations

16.

Vitte, Jérémie, Sabine Traver, A. Maues de Paula, et al.. (2010). Leucine-Rich Repeat Kinase 2 Is Associated With the Endoplasmic Reticulum in Dopaminergic Neurons and Accumulates in the Core of Lewy Bodies in Parkinson Disease. Journal of Neuropathology & Experimental Neurology. 69(9). 959–972. 61 indexed citations

17.

Vitte, Jérémie, et al.. (2009). Spinal Muscular Atrophy. Advances in experimental medicine and biology. 652. 237–246. 9 indexed citations

18.

Vitte, Jérémie, Coralie Fassier, Francesco Danilo Tiziano, et al.. (2007). Refined Characterization of the Expression and Stability of the SMN Gene Products. American Journal Of Pathology. 171(4). 1269–1280. 87 indexed citations

19.

Couturier‐Tarrade, Anne, Coralie Fassier, Delphine Charvin, et al.. (2006). A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Human Molecular Genetics. 15(24). 3544–3558. 146 indexed citations

20.

Vitte, Jérémie, Natacha Roblot, M. Mayer, et al.. (2004). Deletion of Murine Smn Exon 7 Directed to Liver Leads to Severe Defect of Liver Development Associated with Iron Overload. American Journal Of Pathology. 165(5). 1731–1741. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact